Oracle, Parexel International Corporation and ERT Clinical are dominating the North America Electronic Clinical Outcome Assessment (eCOA) Market in 2019

North America Electronic Clinical Outcome Assessment (Ecoa) Market is expected to grow with the CAGR of 15.8% in the forecast period of 2020 to 2027. The years considered for the study are as mentioned below.

Access full Report @ https://www.databridgemarketresearch.com/reports/north-america-electronic-clinical-outcome-assessment-ecoa-market  

North America electronic clinical outcome assessment (eCOA) market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in the North America electronic clinical outcome assessment (eCOA) market are introducing strong range of products provider along with receiving large number of FDA & CE mark approvals for launching new products into the market. For instance, in June 2018, Bioclinica announced the availability of its expanded and enhanced 'SMART' technology suite with combined benefits of medical imaging, EDC and IRT. This efficient product launch with potential of unleasing data transparency and synchronous communication will be beneficial for Bioclinica as it has expanded its product portfolio and will raise its demand in market.

Oracle is the dominating player in the North America electronic clinical outcome assessment (eCOA) market. The other key players existing in the market includes Bioclinica, Signant Health, eClinical Solutions LLC. , ERT Clinical, Kayentis, Omnicomm, Parexel International Corporation, YPrime LLC, Clinical Ink, IBM Corporation, WIRB-Copernicus and among others.    

North America Electronic Clinical Outcome Assessment (Ecoa) MarketOracle:

Oracle is headquartered in California, the U.S. and was founded in 1977. The company focuses on offering integrated cloud applications, platform services and engineered systems to its clients. The company has business segment named as cloud services and license support, cloud license and on-premise license, hardware and services out of which cloud services and license support, cloud license and on‐premise license are the market focused segments. The company also has wide product portfolio including generation 2 cloud infrastructure, on-premise infrastructure, cloud applications, government cloud, industry applications, on-premise applications among which generation 2 cloud infrastructure, on-premise infrastructure, cloud applications, industry applications, on-premise applications are the market focused categories. 

For instance,

  • In February 2020, Oracle launched its Oracle cloud system in five new local regions namely Australia (Melbourne), Japan (Osaka), Saudi Arabia (Jeddah), The Netherlands (Amsterdam) and Canada (Montreal). This market expansion will help Oracle in bringing more consumers towards its cloud based applications which in return will increase its revenue.

The company also has wide global presence across Asia-Pacific, Europe, Middle East and Africa, and Americas. The various subsidiaries includes GoldenGate Software Worldwide LLC (U.S.), Logical Applications, Inc. (U.S.), Logical Apps, Inc. (U.S.), Milano Acquisition Corporation (U.S.), Oracle Credit Corporation (U.S.) among others.

Parexel International Corporation:

Parexel International Corporation is headquartered in Massachusetts, the U.S. and was founded in 1982. The company focuses on the formation of innovative new therapies to improve the healthcare facility across globe by providing biopharmaceutical development services including clinical trial design to regulatory, consulting services to commercial and market access along with therapeutic, technical solutions that help customers across the globe to deduce the information of the scientific discoveries into innovative treatments for patients. The product categories include clinical development, outsourcing services, integrated technologies, regulatory & access consulting, medical communications, medical and scientific services, real-world evidence and late phase, solutions by industry and solutions by development phase among which clinical development, integrated technologies, regulatory & access consulting, and real-world evidence and late phase is the market focused category.

For instance,

  •  In December 2019, Parexel International Corporation announced the starting of their new collaboration hub in the Cambridge Innovation Center (CIC), Cambridge, Mass. This collaboration has helped Paraxel International Corporation to connect and collaborate with the innovation hub at Cambridge and Kendall Square thus helped in its market expansion.

The company has wide presence across North America, South America, Europe, Asia and Middle East & Africa.  

ERT Clinical:

ERT Clinical headquartered in Pennsylvania, the U.S. was founded in 1972. The company focuses on providing risk free data using technology to minimize the uncertainty in the clinical trials. The company offers wide product portfolio categories including safety & efficacy endpoint collection, data integration & analytics & real-world evidence.

For instance,

  • In March 2019, ERT Clinical has announced that it will move its Japan-based offices to an increased facility in central Tokyo. This will benefit ERT in gaining customers from the APAC region which will lead to increased revenue generation in future.

The company has wide presence across North America, Europe and Asia-Pacific.